Founded in October 1992, Sino-US Kunming Baker Norton Pharmaceutical Co.,Ltd.(hereafter abbreviated to be KBN)is the first joint-venture in Yunnan pharmaceutical industries.The shareholders of KBN are Kunming Pharmaceutical Corp, and IVAX Corp., an United States public corporation focused on manufacturing and distributing generic pharmaceutical products.In January 2006, IVAX was acquired by the Israeli company TEVA Pharmaceutical Industries.(ASE:TEVA).And therefore,TEVA became the foreign shareholder of KBN,TEVA Pharmaceutical Industries Ltd.is a global pharmaceutical company specializing in the development,production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients.TEVA is among the top 20 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.